1-1 of 1
Linda Lintz, BA
Close
Sort by
Journal Articles

Azacitidine (Vidaza®) Treatment Response Assessed Using Three Alternative Dosing Schedules in Patients with Myelodysplastic Syndromes (MDS).

Roger Lyons, MD, Thomas Cosgriff, MD, Sanjiv Modi, MD, Linda Lintz, BA, C.L. Beach, PharmD, Jay T. Backstrom, MD, MPH
Journal: Blood
Blood (2005) 106 (11): 2517.
https://doi.org/10.1182/blood.V106.11.2517.2517
Published: 2005